The Prometheus League
Breaking News and Updates
- Abolition Of Work
- Ai
- Alt-right
- Alternative Medicine
- Antifa
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ascension
- Astronomy
- Atheism
- Atheist
- Atlas Shrugged
- Automation
- Ayn Rand
- Bahamas
- Bankruptcy
- Basic Income Guarantee
- Big Tech
- Bitcoin
- Black Lives Matter
- Blackjack
- Boca Chica Texas
- Brexit
- Caribbean
- Casino
- Casino Affiliate
- Cbd Oil
- Censorship
- Cf
- Chess Engines
- Childfree
- Cloning
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Covid-19
- Cryonics
- Cryptocurrency
- Cyberpunk
- Darwinism
- Democrat
- Designer Babies
- DNA
- Donald Trump
- Eczema
- Elon Musk
- Entheogens
- Ethical Egoism
- Eugenic Concepts
- Eugenics
- Euthanasia
- Evolution
- Extropian
- Extropianism
- Extropy
- Fake News
- Federalism
- Federalist
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom
- Freedom of Speech
- Futurism
- Futurist
- Gambling
- Gene Medicine
- Genetic Engineering
- Genome
- Germ Warfare
- Golden Rule
- Government Oppression
- Hedonism
- High Seas
- History
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Immortality
- Human Longevity
- Illuminati
- Immortality
- Immortality Medicine
- Intentional Communities
- Jacinda Ardern
- Jitsi
- Jordan Peterson
- Las Vegas
- Liberal
- Libertarian
- Libertarianism
- Liberty
- Life Extension
- Macau
- Marie Byrd Land
- Mars
- Mars Colonization
- Mars Colony
- Memetics
- Micronations
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- Nanotech
- National Vanguard
- NATO
- Neo-eugenics
- Neurohacking
- Neurotechnology
- New Utopia
- New Zealand
- Nihilism
- Nootropics
- NSA
- Oceania
- Offshore
- Olympics
- Online Casino
- Online Gambling
- Pantheism
- Personal Empowerment
- Poker
- Political Correctness
- Politically Incorrect
- Polygamy
- Populism
- Post Human
- Post Humanism
- Posthuman
- Posthumanism
- Private Islands
- Progress
- Proud Boys
- Psoriasis
- Psychedelics
- Putin
- Quantum Computing
- Quantum Physics
- Rationalism
- Republican
- Resource Based Economy
- Robotics
- Rockall
- Ron Paul
- Roulette
- Russia
- Sealand
- Seasteading
- Second Amendment
- Second Amendment
- Seychelles
- Singularitarianism
- Singularity
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Spacex
- Sports Betting
- Sportsbook
- Superintelligence
- Survivalism
- Talmud
- Technology
- Teilhard De Charden
- Terraforming Mars
- The Singularity
- Tms
- Tor Browser
- Trance
- Transhuman
- Transhuman News
- Transhumanism
- Transhumanist
- Transtopian
- Transtopianism
- Ukraine
- Uncategorized
- Vaping
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Waveland
- Ww3
- Yahoo
- Zeitgeist Movement
-
Prometheism
-
Forbidden Fruit
-
The Evolutionary Perspective
Daily Archives: June 18, 2021
Bringing Abolition to the Museum – Boston Review
Posted: June 18, 2021 at 7:38 am
Shellyne Rodriguez,Hillary Paints a Banner(2020). Colored pencil on paper, 14 x 19 in. Used with permission of the artist.
When COVID hit, the Museum of Modern Art fired its freelance educators, including artist-activist Shellyne Rodriguez. In this interview,Rodriguez places that in a wider critique of museum labor practices, and discusses how Strike MoMA imagines a future of art for the people.
Since early April, artists and workers have occupied the public square across from the Museum of Modern Art (MoMA) in Manhattan. Under the name Strike MoMA, they are protesting the financial entanglements of the museums wealthy patrons as well as the institutions labor practices, including the furloughing of many employees during the COVID-19 pandemic. Building on the momentum of the past years social justice movements, Strike MoMA has pushed back on half measures offered to placate protesters. Organizers claim that only a radical readjustment will resolve their concerns about the museums ties to policing and crony capitalism. The coalition recently garnered support from artist groups such as Guerrilla Girls and Decolonize This Place, as well as activist-intellectuals includingAngela Davis, Fred Moten, Sandy Grande, and Gayatri Spivak. Demonstrations were propelled into national news again in recent weeks when activists clashed with museum security guards, despite director Glenn Lowrys assurance that MoMA would respect peaceful actions.
I envisioned myself as a rank-and-file worker who was demystifying the museum. My approach was to point out that these artworks and their creators are our allies, but this space is not.
For Shellyne Rodriguez, an artist and writer based in the Bronx, this protest is a natural progression. As a community organizer, she helps call attention to the relationships between art, real estate, and gentrification. As an educator at MoMA for nearly a decade, she did work that was in many ways an extension of her activism: running programs for MoMA that mainly took place outside of the museum and connected under-resourced and incarcerated populations with art. When COVID-19 shut down museums across the United States, MoMA terminated contracts for Rodriguez and nearly a hundred other educators, leading to public scrutiny of their precarious employment. Critics questioned why some of the museums most crucial workers were contracted on a freelance basis and not even considered employees of the institution. In a recent conversation, Rodriguez and I connected the dots between these layoffs, the continued resistance to MoMA, and a growing institutional critique rooted in abolition.
Billy Anania
Billy Anania: What were your main responsibilities at MoMA, and why do you believe the educators were among the first to be permanently terminated?
Shellyne Rodriguez: I worked there for about eight years in the education departments community and access programs, which connect schools and nonprofits with the museums art workshops. I helped out with the Alzheimers project, the Touch Tour for the visually impaired, the Primetime Initiative for senior citizens, and much more.
I also worked in community partnerships with Kerry Downey, who has written extensive critiques of community education in museums. These initiatives to bring arts education into the community are generally administered through contracts between the museum and nongovernmental organizations (NGOs), which is pretty problematic. NGOs do not really represent a community; they are an extension of the welfare state. They provide services that used to be public goodspicking up the pieces that the state has neglected or let go due to austeritythrough the same kinds of questionable philanthropy as museums. But the communities they served really interested me and kept me there. I worked with Passages Academy, which is the education wing of the youth detention system in New York, including Crossroads and Horizon Juvenile Centersbasically jails for minors. I got to work with incarcerated kids, sex workers, undocumented children waiting to be reunited with their families, all in different locations. These programs were carved out long before I got there, and I inherited them.
Additionally, I started a whole new initiative in the museum called Night Studio. Im a GED kid who sort of fell through the back door of art school and managed to get some degrees, but I really wanted to create something for folks who were no longer teenagers. There are always programs for teens to get them involved in the arts, but I was interested in collaborating with people in their mid-twenties and thirties who were just coming around to getting a high schoolequivalency diploma, and who self-identified as artists but did not have any avenues to be supported in that. I started this program with the museums money, of course. It was intensive with lots of resources, and we taught them a great deal.
I envisioned myself as a rank-and-file worker who was demystifying the museum, but not necessarily trying to make people of the museum. My approach to education was pointing out that the collections are relics that artists originally made to say something, but which are now captured in this space. These works and their creators are our allies, but this space is not. I often used the museum for political education, because that is just my approach to teaching. In general, I tried to spend as little time there as possible. Art institutions try to pay in social capital, but I wasnt interested in that.
The museum used underpaid contract positions to make itself seem more committed to community initiatives than it in fact was.
BA: Given that your employment by MoMA was so contingent, it seems bizarre that the museum expected you to be so heavily invested in the company culture. But it seems clear that the museum used these underpaid contract positions to make itself seem more committed to these initiatives than it in fact was.
SR: Oh, I was basically operating as a program director, but, in reality, I was a gig worker. When the museum laid us all off, I was pissed that I no longer had a job, but I wasnt shocked. Of course education goes first; this is Neoliberalism 101. I have always seen the museum for what it is, and I did not expect some kind of benevolent action to occur. Glenn Lowry, the museums director, is basically a corporate CEO after all.
I was more offended the year before COVID-19 hit, when all the freelance educators were disinvited from the annual holiday party. Human resources reminded us that we were technically not museum employees, so we could no longer attend. I had been there for more than seven years, and others had been there for as many as thirty years. We were all appalled. Our immediate supervisors, who had no real power, said they would organize a dinner just for our department. I felt more insulted by this incident than anything else, but it was merely a liability issue for the museum. They wanted to avoid any circumstances in which they appeared to acknowledge we were actual employees of theirs. It was the most honest thing they ever did.
BA: It feels necessary to contextualize the educators within MoMAs broader labor structure. Museums tend to keep their workers as separate as possible, and they often farm out front-facing positions to third parties (including to private security companies, temp agencies, and catering companies), all while poorly compensating these workers and offering them no potential for union representation. But there is also more than one union at the museum, with different ones for blue- and white-collar workers, right? This is a business model that has been broadly adopted by museums (and with clear parallels to the neoliberal university), with a professional class of administrators and curators, then laborers who execute much of the museums daily operations and work under precarious conditions.
There is this mythology around museums that needs to be debunked. They are corporations like any other, except that their businesses accrete around a bonfire of fetishized art.
SR: There is this mythology around museums that needs to be debunked. They are corporations like any other, except that their businesses accrete around a bonfire of fetishized art. I am not sure why we ever expected any better from a corporation. Of course they treat their workers terribly and carry out union-busting tactics.
Union workers only comprise a small percentage of employees at MoMA, but the fact that there are unions gives the public a false impression that the museums workers have a seat at the table. In reality, business decisions are all happening multiple tax brackets above the vast majority of both unionized and nonunionized workers. Security at MoMA is unionized, but that is a whole other dilemma. Management always wants to make sure the cops are comfortable.
BA: The directors and trustees are not really beholden to every department, and many white-collar workers may not even know some departments or positions even exist. That is a known tool of union-busting: a portion of employees are given recognition while everyone else is left scrambling, thereby disrupting worker unity. In one sense, you have a unified group of workers agitating for short-term solutions, but can unions also wind up extending the life of longer-term issues?
SR: Well, the problem is that unions cannot solve everything. If we clamor for more unionization in the museum, then what do those contracts look like? I am thinking about how many times public sector unions bailed out New York City. The pensions of teachers and multiple city workers get invested into the bonds that keep the doors of state and federal prisons open. Its all intertwined. This is something that is addressed in Strike MoMAs Post-MoMA Futures platform. We are not going to fix these big problems by unionizing; that would just get us more of the same. Where does the money come from? Where do the pensions go? Once unions are involved in upholding the structure, because their pensions are on the line, they can actually start working to uphold the very people and structures Strike MoMA is protesting. Yes to collective bargaining power, but the devil is also in the details.
Once unions are involved, because their pensions are on the line, they can actually start working to uphold the very structures Strike MoMA is protesting. Yes to collective bargaining power, but the devil is also in the details.
BA: Can we talk more about Strike MoMA? How have the last few months shifted the conversation around museum futures?
SR: One idea that fascinates me is interconnected struggle, or an interlocking directorate. This term is loosely defined as the networks of oligarchs, multinational corporations, and defense industry profiteersthe cluster formed by those holding executive positions at companies while sitting on museum and university boards.
Strike MoMA recently highlighted MoMA trustee Gustavo Cisneros, who pretty much embodies the Latin American art empire; there is no bigger name than that. He also happens to sit on the board of Barrick Gold Corporation, which is the worlds largest gold mining company. They have committed atrocities all across the world: bodies piled up in East Africa, natural reserves decimated, loads of problems in South America.
BA: In the last five years, Barrick Gold has come under fire for its backdoor deals with Tanzanian policewho subsequently murdered more than sixty villagersas well as a controversial Chilean project shut down by that countrys environmental regulator, and cyanide spills in Argentina. Now theres talk of another mine project and tailings dam in the Dominican Republic, despite organized opposition on the ground there.
SR: Yes, and New York City makes up a huge portion of the Dominican diaspora, so this is of great concern here, too. Cisneross company wants to build a dam on a river that more than 4 million people depend upon, including people living in the capital, Santo Domingo. Cow and rice farmers, along with other people in that region, are engaged in guerilla tactics to stop this, fighting against officials and police who are backing Barrick Gold. Cisneros is also building a sustainable luxury resort in the Dominican Republic while all this is going down.
Then we have James and Paula Crown. They funded the Crown Creativity Lab at MoMA, and even named one of its programs The Peoples Studio. The Crowns own General Dynamics, which manufactures and sells the weapons used to carpet-bomb Gaza. They have been selling these same bombs to the Saudis, who have used them to ravage Yemen, and they sold battle tanks to the Colombian military forces that are now all over the streets raining hell on Colombians.
BA: Another MoMA board member, Steven Tananbaum of GoldenTree Asset Management, owns a significant portion of the sovereign debt of Puerto Rico. Tananbaum once boasted to Reuters about how forcing a restructuringof the commonwealthsdebtin effect guaranteeing it remain poorcould turn a fantastic profit for investors. And he is not even the only MoMA trustee working with the hedge funds enforcing Puerto Ricos debt. Theres also Leon Black, who recently stepped down for his associations with Jeffrey Epstein, as well as billionaire investors Daniel Och and Glenn Dubin. The global impact of this museum board alone feels insurmountable.
SR: These folks all work in solidarity together. They control their own domain, but they also wield significant power in our civic spaces where we go to work. And if they are working together, then we need to do the same. As someone who worked at MoMA for a long time, I cant sit this out.
These board members all work in solidarity. And if they are working together, then we need to do the same.
BA: I read your 2018 essay in the New Inquiry, titled How the Bronx Was Branded, and thought it was one of the most succinct explanations of how art and real estate work together. You showed that at the heart of the Bronxs redevelopment was a lofty public relations campaign that allowed artists, developers, and city officials to profit off the displacement of low-income families. How do museums contribute, and can you speak about the PR war they wage on the media and ordinary people?
SR: When I organize with Take Back the Bronxa volunteer grassroots collective centered around community controlI try to bring in how art contributes to gentrification here. This is how I first connected with Decolonize This Place, because they were thinking about museums all over the world in similar ways. The Bronx is the poorest borough in New York, with two of the poorest congressional districts in the country. We have a huge Yemeni community and a lot of Palestinians, too. We have spent so much time bridging the gaps in our communities to enrich conversations and inspire people to feel empowered by the spirit of interconnected struggle.
Museums exist in a market, just like real estate, and we are all somewhat in denial because they happen to be tied to something we love. I would never deny the levels of spirituality and poetics we all experience through art; that is the reason Im here. But we cannot conflate art with museums. They are not synonymous, nor are art and for-profit art galleries synonymous. We let these millionaires and billionaires convince us that their spaces are the only ones that legitimize art, and suddenly no other alternatives seem possible.
However, we are starting to see this all break down a little bit. While other museums were getting a lot of bad press for taking money from the Sacklers and oil companies and the like, the MoMA managed to stay off the radar for a long while. But recently there was an open letter signed by quite a few prominent scholars and artists denouncing the museums position on Palestine. Its the beginning of a conscious shift. I think people still feel some sort of religious feelings toward MoMA, you know? Thats our mistake. There is significant power on that board that cannot be overlooked.
We let millionaires convince us that their spaces are the only ones that legitimize art, and suddenly no alternative seems possible.
BA: I think many of us have only recently had our eyes opened to the myriad ways that money laundering factors into museum leadershiphow wealthy philanthropists can basically art-wash their wealth to uphold a positive reputation centered around humanity and creative expression.
SR: And this is part of a larger question: Are we, as artists and cultural workers, willing to engage with this problem? Are we willing to make it so the structures we have relied on, which hold these museums together, are rendered obsolete?
I remember during the first days of protests at the Whitney Museum in 2019we were protesting Whitney vice chair Warren Kanders, who owns weapons manufacturer Safariland Groupwhen a well-known art critic stopped by. He sauntered over and started yelling at some of the young people putting up banners, saying they had no respect and that we need these philanthropistsand that we were not old enough to remember the Culture Wars. I think the argument he was trying to make was that the government cant be counted on to fund museums, so we need to rely on the private sector. And of course the government routinely begs the private sector for help. Neoliberalism is the private sector governing, and this is just an extension.
People say, How will we take care of art? or How will we take care of the museum? To me, those are classist questions. How much of a museum collection is extracted? I am thinking of the MOVE bombing victim whose remains recently were revealed to be in the collection of the Penn Museum, and the price our communities pay because people want to keep the museum doors open. Its a bait and switch, like bombing a city and building a school.
BA: Yes, it feels as though this corruption and exploitation are inevitable outcomes of institutions founded on colonialist practices.
SR: A hundred percent. I have gotten so much out of speaking with and reading Ariella Asha Azoulay, particularly her book Potential History: Unlearning Imperialism (2019). Ariella could be a battle rapper; shes got bars. She makes an example of the camera shutter, the action that locks a historical moment into place and crystalizes its story. You will see photos in the newspaper of rappers like DJ Kool Herc and Swizz Beatz applauding a new hip-hop museum. That captured image of the museum, the crowds, and the applauding does not capture the periphery, which is the bulldozing of communities and gentrification occurring outside.
This is also how an imperialist project is born, and how art replaces humanity inside the museum. When the vitrine goes in, we go out. Its rooted in a death; once they put the shell-top Adidas behind the glass, they dont need the people anymore. They have the fossil, the souvenir, the head on a spike. That is the violence of modernityas Arthur Schopenhauer used to say, that art plucks the object of its contemplation from the stream of the worlds course, and holds it isolated before it. The museum wrenches the object from the world and holds it up for us. What gets left behind is murder, extraction, pillaging, and colonialism.
The museum wrenches the object from the world and holds it up for us. What gets left behind is murder, extraction, pillaging, and colonialism.
BA: I feel particularly drawn to this quote of yours from that New Inquiry essay: How would an artistic practice that aims to disrupt alienation appear in our hallways, elevators, and all the spaces we share in our communities? Have you found an answer to this?
SR: When we reweave the social fabric, the middleman is clearly what needs to be abolished, and abolishing the mediator means we talk to each other again. And when we talk to each other again, we can break down the alienation. One thing I have always admired about immigrant communities is how tightly knit they are, because they have not yet experienced the alienation of the metropolis. In contrast, for Black and Puerto Rican communities that have been here since the 1950s, it is much more difficult. We have gone through too much, been broken apart and separated to an extreme degree. We are an expendable labor force that experienced the first wave of the neoliberal project, which is why we also make up so much of the prison.
Alienation affects everybody in the city, though, and makes us all exist in separate worlds with our shared grievances. This came up during the 201920 FTP protests, when protestors challenged the New York police in the subway. Everyone was mad in their heads, but nobody was vocalizing it. How do we continue to crack that? I think it might require dialing back before all the organizing work, before knocking on doors, before galvanizing around the problemhow do we see each other? Its about locating that beginning point.
BA: In applying an abolitionist critique to museums, do we risk taking away from the contemporaneous prison/police movements? Or are they all interrelated?
SR: Abolition as a principle is not just about police. The museum is the police precinct, as Stefano Harney said in a recent talk, meaning these institutions are the well-funded gatekeepers of culture within a city of aesthetically minded people. They are involved in community policing, sending patrol cars in the form of curators and community outreach. We need to stop thinking about the police as the person in the blue uniform. That is just one pawn, not the whole picture. The police is the structure, and that structure takes many forms. Nonprofits and NGOs are police. We are talking about structures of power, and if we are undoing these structures, then that is abolition by definition.
Abolition as a principle is not just about police. The museum is the police precinct, meaning these institutions are the well-funded gatekeepers of culture.
How do we put this critique into practice and build toward these institutions being obsolete? This is why Strike MoMA is so categorically different from the Whitney Museum protests. Back then, it was about shining a light on one board member, to make an example of how one person touches all of our struggles. Warren Kanderss weapons were in Ferguson, in Palestine, in Puerto Rico, and at the border. With Strike MoMA, there is something growing in the park right across the street from the museum. We have been so conditioned to have the state mediate our every move and conflict, from loud music complaints to applying for welfare. A mediator is present at all times. Pushing that middleman out is abolition in practice; struggling to eliminate the need for the mediator is abolition. We call them no-cop zones. We do not need the police if we can handle the disagreements ourselves. We just need to learn how to talk to each other, and how to undo systemic problems for ourselves.
We apply this same principle to the museum. No one needs to stay awake at night, stressed out and ruminating over what will happen to art and artists if we drive out all the toxic philanthropistsas if philanthropy isnt toxic in and of itself. This is art were talking about, after all. The lack of imagination really kills me sometimes. This is supposed to be our space. What are we going to build next?
See the rest here:
Posted in Abolition Of Work
Comments Off on Bringing Abolition to the Museum – Boston Review
The Chains of Slavery Still Exist in Mass Incarceration – Vera Institute of Justice
Posted: at 7:38 am
The 13th Amendment may have outlawed the enslavement of Black people, but the United States continues to devise new ways to uphold the racist hierarchies that slavery was founded on and to restrict the freedom of the descendants of enslaved people.
Today, we see alarming echoes of the Reconstruction Era, when unjust laws prevented emancipated enslaved people from voting and exercising their power and influence as citizens of a democracy. During the 2020 presidential election, people who lived in predominantly Black neighborhoods faced significantly longer lines to cast ballots than people in predominantly white neighborhoods. In some cases, Black people were forced to wait more than five hours to vote. Now, lawmakers in 43 states have proposed at least 250 bills that would make voting more difficult. Historians say that these proposalswhich include ID requirements, reduced poll hours, and limits on mail-in votingwould represent the most dramatic curtailment of ballot access since poll taxes, literacy tests, and other restrictions effectively prevented newly emancipated men from voting in the late 19th century.
Obstacles to voting are just one means to curtail the liberty of Black people in the United States. Mass incarceration has picked up where slavery left off, separating families and dehumanizing and traumatizing the descendants of enslaved people. In the 156 years since slavery was abolished, Black people in the United States have gone from being considered less than human under the law to being treated as less than human by a criminal legal system that still punishes them more harshly than white people at every stage.
Because the 13th Amendment exempted people convicted of crimes, the criminal legal system has been used to extract labor from enslaved peoples descendants. Immediately after the abolition of slavery, Black codes criminalized activities like selling crops without permission from a white person. Other laws criminalized Black people for being too close to a white person in public, walking without purpose, walking next to railroad tracks, or assembling after dark.
As lawmakers expanded the criminal legal systems ability to arbitrarily send Black people to jail for minor crimes, convict leasing laws allowed plantation owners to lease convicted people. Historians have reported that people who were leased were treated even more brutally than enslaved people because plantation owners had a financial incentive to keep enslaved people alive. No such incentive protected victims of convict leasing. Most incarcerated people who were leased for labor did not even survive to complete 10-year sentences. Until the mid-1950s, states routinely forced chain gangs of imprisoned people to do public works projects while wearing chains weighing as much as 20 pounds.
While Black codes and chain gangs have faded into history, incarcerated people remain an easily exploitable labor source because desperate conditions compel many to accept any work for any pay just to alleviate some of the misery of their circumstances. Private companies and governments extract nearly free labor from incarcerated peoplewho are employed to do everything from building office furniture and making hand sanitizer to staffing call centers and performing 3D modelingin most cases for pennies an hour. In California, incarcerated people battle fires in 24-hour shifts for as little as $2.90 a day. The estimated minimum annual value of prison and jail industrial output is $2 billion.
It is long past time for the United States to abolish this modern twist on slavery. The labor of all people, including those who are incarcerated, deserves respect and fair pay. Freedom Unitedand National Equal Justice Association are two organizations which have campaigns to end these exploitive practices.
As the country commemorates Juneteenth, a holiday that celebrates the emancipation of enslaved people in the United States, remember that slaverys chains still rattle. Voter suppression is on the rise, and mass incarceration is another incarnation of state-sponsored, economically incentivized institutional terror that destroys the lives of Black people and many others in this country. This Juneteenth, Vera is redoubling our efforts to uproot slaverys lasting legacy and build a nation where all people are treated with dignity and respect.
Read the original:
The Chains of Slavery Still Exist in Mass Incarceration - Vera Institute of Justice
Posted in Abolition Of Work
Comments Off on The Chains of Slavery Still Exist in Mass Incarceration – Vera Institute of Justice
A-G, govt at odds as 23 posts abolished – The Tribune India
Posted: at 7:38 am
Chandigarh, June 17
Punjab Advocate-Generals office has plunged into a crisis of sorts. Just about seven months before the Assembly polls in the state, differences have surfaced between Advocate-General Atul Nanda and the government, evident from the abolition of 23 not-so-high-level posts without consulting him. His wife and Additional Advocate-General Rameeza Hakim, too, has resigned from the post she held for more than four years.
Reacting to arbitrary abolishment of posts in his office, Nanda has shot off a communiqu to Chief Secretary Vini Mahajan, asserting the Home Department abolished 23 posts without so much as the courtesy of consultation with me to affect the functioning of his office. Nanda added some of the posts, including those of steno and librarian, were critical for the functioning of any lawyers office. The next six months are crucial as being end of the term. The government is likely to be faced with critical litigation, which will require this office to work at its best. At a time like this, to try and cripple my office with the abolishing of posts, betrays an arbitrary approach if not, a total non-application of mind by the ACS Home. TNS
The rest is here:
Posted in Abolition Of Work
Comments Off on A-G, govt at odds as 23 posts abolished – The Tribune India
Government suspends work of jury reform group due to other priorities – The Irish Times
Posted: at 7:38 am
The Government has quietly suspended an ambitious programme of reform of the jury system as a result of other priorities.
The Working Group on Jury Service was established in 2018 to examine a range of issues including whether jurors should receive expenses and the potential widening of the jury pool.
Tougher laws to prevent jury tampering or intimidation were also to be considered by the group, as were specific laws against jurors disclosing the details of their deliberations after a trial.
It was also responsible for examining the abolition of the effective blanket ban on civil servants and certain professionals from jury service.
Under the current system, a wide range of people, including doctors, nurses, teachers and public servants, are excused as of right from jury service. This has led to concerns that juries are not truly representative of society.
The working group was established to examine 56 recommendations contained in a 2013 Law Reform Commission report. The report called for radical reform of a jury system which has remained essentially unchanged since the automatic exemption for women was abolished in 1976.
The working group was made up of senior officials from the Department of Justice, the Courts Service, Forensic Science Ireland, the Garda and the Director of Public Prosecutions office.
It met a number of times between April 2018 and April 2019 before ceasing work without delivering a final report.
Unfortunately other priorities then overtook the work of that group, a department spokesman said when asked why it had ceased meeting.
The department said the modernisation of the courts system remains a priority and that the operation of the jury system will be further reviewed in the future. This will include the work already carried out by the working group and any subsequent developments, in particular over the course of the pandemic, the spokesman said. Any reforms would of course require primary legislation.
The working group had asked legal experts and various groups in the justice sector, such as the Law Society, to make submissions on the topic of jury reform before it ceased work. The unannounced cessation of its work has caused frustration among some of those who made submissions.
One of those was Dr Mark Coen, a law lecturer and jury expert in UCD, who made a submission with his colleague Dr Niamh Howlin.
He said it appears the department shut the working group down and hoped nobody would notice.
The working group wrote directly to people, including me, seeking written submissions. However, the working group did not extend those of us who responded with written submissions, in February 2019, the courtesy of updates on what it was doing with those submissions, if anything, Dr Coen told The Irish Times.
The whole episode has not exactly been a model of best practice in conducting public consultation.
Dr Coen said he emailed the department several times seeking an update on the groups work but did not receive a response. He eventually contacted the departments secretary general and was told the working group has been put on hold due to competing priorities.
See the original post here:
Government suspends work of jury reform group due to other priorities - The Irish Times
Posted in Abolition Of Work
Comments Off on Government suspends work of jury reform group due to other priorities – The Irish Times
Exhibition to mark slave-owner turned Abolitionist John Newton – Church Times
Posted: at 7:38 am
THE contentious issue of commemorating in churches and cathedrals the lives of those who had been involved in the slave trade arose in the Consistory Court of Oxford diocese in a petition for a faculty to create an educational area dedicated to the life and work of the Revd John Newton (1725-1807), in the Grade I listed Church of St Peter and St Paul, Olney.
Newton was described in The Dictionary of National Biography (2010) by D. Bruce Hindmarsh as a slave trader and Church of England clergyman who had been accused of hypocrisy for holding strong religious convictions at the same time as being active in the slave trade, praying above deck while his human cargo was in abject misery below deck. Later in life, and after he had left the sea, he repented and supported the movement for the abolition of the slave trade.
An entry by Historic England stated that his singular position as a figure of unimpeachable moral authority with first-hand experience of the slave trade made his contribution to the success of the abolition movement extremely valuable.
The petition for the faculty was unopposed, and was brought by the Rector, the Revd Andrew Pritchard-Keens, and two churchwardens of St Peter and St Paul (the petitioners), where Newton had been an assistant curate from 1764 to 1780. On New Years Day 1773, he delivered a sermon, based on a hymn that he had written a few days earlier, Faiths Review and Expectations. That hymn later became Amazing Grace, and Olney came to be known, as the road sign into Olney proclaimed, The home of Amazing Grace.
In 1779, a book was published, Olney Hymns, written by Newton in collaboration with his close friend the poet William Cowper (1731 to 1800). It had 67 hymns by Cowper, and 281 by Newton, including Glorious things of thee are spoken and How sweet the name of Jesus sounds.
In 1780, Newton became Rector of St Mary Woolnoth, in the City of London, and while there he formed a strong relationship with William Wilberforce, whom he advised and supported in the campaign to abolish slavery. Newton and his wife were originally buried in the crypt under St Mary Woolnoth, but their remains had to be moved to accommodate the extension to the London Underground Northern Line, and the construction of Bank Underground Station. Their remains were transported to Olney, and interred in a tomb that is now a Grade II listed monument.
The Church of Englands guidance for parishes and cathedrals addresses concerns over memorials with links to slavery (News, 14 May). It notes that, although churches and cathedrals are, above all, places dedicated to the worship of God, not all members of the local community feel welcome there, and that might be because of the presence of objects commemorating people who were responsible for the oppression and marginalisation of others.
The report of the Archbishops Anti-Racism Taskforce also recognised that, while history should not be hidden, the Church did not want unconditionally to celebrate or commemorate those who had contributed to or benefited from the tragedy that was the slave trade (News, 23 April).
Given the sensitivity and relevance of Newtons involvement in the slave trade, the petitioners clarified how they proposed to approach the subject of the slave trade in their exhibits, which had been donated by the Cowper and Newton Museum, in Olney. They said that they intended to celebrate Newtons Christian conversion, his life as an evangelist and hymn-writer, and his inspiring relationship with Wilberforce. But they did not intend to sanitise or airbrush history and would highlight the evils of the slave trade and all that it involved. They also intended to celebrate Amazing Grace.
The Chancellor, the Worshipful David Hodge QC, said that, since the proposal was one that essentially involved the historical associations of the church and its cultural, ethical, and heritage values, it was not a proposal that, if implemented, would result in any harm to the significance of the church as a building of special architectural or historic interest. The ordinary presumption in faculty proceedings in favour of things as they stood had also been rebutted.
The planned changes were designed to bring into regular and beneficial use what was presently a little-used area of the church, and to ensure that it was available to educate visitors, in a balanced way, about Newton, his life and work, and to celebrate his later, and worthy, achievements while not overlooking or in any way seeking to diminish his earlier sins, the Chancellor said. As the home of Amazing Grace, with significant connections to Newton and Cowper, the church already attracted thousands of visitors every year, and the changes that were being proposed would serve only to enhance the visitor experience, thereby enhancing the churchs mission.
The Chancellor said that the new displays would serve to remind the worshipping congregation and visitors that Jesus came to call not the righteous but sinners to repentance (Luke 5.32), and would also bring to mind the true saying of St Paul, worthy of all to be received, That Christ Jesus came into the world to save sinners (1 Timothy 1, 15), as they were instructed during the service of holy communion according to the Book of Common Prayer.
From the material presented to him, the Chancellor said, it appeared that the church was alive to the need to ensure that there was appropriate diversity amongst the materials to be displayed . . . and to recognise the vital contributions made to the abolition of the vile trade in human flesh by African and other global majority heritage writers and abolitionists, women and working-class reformers, rather than simply focusing upon the work of prominent white, upper- and middle-class male abolitionists like John Newton and William Wilberforce.
The faculty was therefore granted for the proposals to be implemented within six months.
See the original post:
Exhibition to mark slave-owner turned Abolitionist John Newton - Church Times
Posted in Abolition Of Work
Comments Off on Exhibition to mark slave-owner turned Abolitionist John Newton – Church Times
Conservative Creation: New Institutions to Preserve What We Hold Dear – Philanthropy Magazine
Posted: at 7:38 am
Earlier this year Andy Smarick, senior fellow at the Manhattan Institute, wrote a compelling piece in Public Discourse advocating a conservatism of creation. Noting that conservatives are typically adept at well, conserving, he exhorts them to also get great at creating new institutions. For readers who may see conservative creation as an oxymoron at first glance, Smarick assures them that it is, in fact, just what our nation needs to maintain the most important aspects of society, culture and governance.
Perpetual institutions are necessary for ongoing needs, he acknowledges, though they may require updating and reform from time to time. In times of massive change, however, conservatives might better discriminate between the perpetual institutions we need (family, marriage, national and state legislatures) and those which we simply happen to have. Rather than spending precious time and money doing the incremental work of fine-tuning the latter, conservatives should look to those extraordinary eras when Americas civil society exploded with institutional fertility.
The years between 1820 and 1860 marked one such period, driven by the Second Great Awakening; reformers championing abolition, temperance and womens rights and the founding of many new colleges and universities. Smarick also cites the years between 1880 and 1920 when the Red Cross, NAACP, Boy and Girl Scouts and many other organizations were established. For conservatives, however, the real Golden Age was the two-decade organization spree between 1964 (Barry Goldwaters loss) and 1984 (Ronald Reagans landslide re-election) when conservative social entrepreneurs and donors established numerous institutions (including the Federalist Society, the Heritage Foundation, and the Manhattan Institute) which pushed conservative ideas forward and continue to do so today.
In encouraging a rebirth of conservative creation, Smarick deftly links such action to the conservative intellectual tradition, citing Alexis de Tocqueville, Robert Nisbet and Friedrich Hayek. He is equally careful to avoid advocating change in place of continuity, referring to Edmund Burkes comment that a state without the means of some change, is without the means of its own conservation. He cautions conservatives to avoid looking to national solutions for the problems they choose to tackle and turn instead on social entrepreneurialism that is focused more locally, that produces a diversity of institutions and that engages our fellow citizens in collective action.
And finally, Smarickaware of the frustrations that conservatives may face in attempting to reform perpetual institutions (and higher education comes immediately to mind)asks them to stay in those fights. We need to be part of the debates that take place inside of and about longstanding entities, he writes. But we must also appreciate that sometimes in order to preserve principles and practices that we hold dear, we must create new institutions dedicated to such causes.
For donors and others interested in following Andy Smaricks work around conservative creation, the Manhattan Institute held an event on June 2 titled A Conservatism of Creation: Building New Education Institutions. You can access it here.
Original post:
Conservative Creation: New Institutions to Preserve What We Hold Dear - Philanthropy Magazine
Posted in Abolition Of Work
Comments Off on Conservative Creation: New Institutions to Preserve What We Hold Dear – Philanthropy Magazine
Peru’s Election Commission says it is working at maximum speed to resolve election questions – Texasnewstoday.com
Posted: at 7:38 am
File Photo: Peruvian Presidential Candidate Pedro Castillo addresses supporters from the headquarters of the Free Peruvian Party in Lima, Peru, June 8, 2021.Reuters / Sebastian Castaneda
June 17, 2021
Marco Aquino and Stephanie Eschenbacher
Lima (Reuters) -Perus Election Commission voted against the June 6 presidential election on Thursday to quickly declare the final result and end the swirling tensions and uncertainties. He said he was working at maximum speed to check.
National Election Jury President Jorge Saras said in a Twitter message that all staff members of the organization would work to ensure that the checks on the votes contested throughout the weekend were accelerated.
Socialist Pedro Castillo claimed victory https://www.reuters.com/world/americas/perus-castillo-leads-election-with-501-votes-after-all-ballots-tallied-2021- 06-15 This weeks votes were slightly higher than his right-wing rival Keiko Fujimori. However, Fujimori vowed to fight, denying her party allegations of fraudulent elections that provided little evidence.
Election experts said the task of checking the disputed votes could take days or weeks, given that the Fujimori Party has demanded the abolition of about 900 voting tables.
In the 2011 and 2016 elections, Fujimori also ran and was defeated, but the official announcement of the winner was made until the end of June, and the number of votes was reduced.
Castillo has recently met with presidential candidates, other political party representatives, and civil society groups who ran in the first round of the election to build a bridge to form a government.
A clear election of 51-year-old former teachers and union leaders in power of the party in support of Marxist ideas is https://www.reuters.com/world/americas/stashing-cash-perus-urban-elite -Panics-socialist-looks-set-clinch-presidency-2021-06-15 A small urban elite in Peru.
Questions have also been raised about the possibility of a new wave of leftist government in South America, with elections scheduled in Chile, Colombia and Brazil within the next 18 months. Like Peru, everything is characterized by increasingly polarized political and economic problems exacerbated by the COVID-19 pandemic.
Castillo claims https://www.reuters.com/world/americas/perus-socialist-president-in-waiting-seeks-calm-fears-amid-vote-tension-2021-06-16. He is not a communist and uses democratic means to redistribute wealth. But his promise to renegotiate mining taxes and abolish the countrys constitution surprised investors.
Ordered Regime Change
In a note on Thursday, JP Morgan said a more moderate message delivered by Castillo and his team as the vote lowered mass blood pressure.
Reaching out to more centrists will usher in a story of moderation, opening the door to moderate regime change scenarios, he added.
With 100% of the votes counted on Tuesday, Castillo was ahead with 50.125%, 44,058 votes behind Fujimori, the daughter of former president Alberto Fujimori, who was imprisoned.
The tough elections have deeply divided the Peruvians. Protest marches by supporters of both candidates take place almost daily in downtown Lima, calling for a quick resolution and respect for the will of the masses.
Julio Lewis, chief economist at Itau Bank in Brazil in Mexico and Peru, said the impasse in elections and the resulting delay in announcing the new governments economic policies could also have a ruthless impact on investment.
At a press conference on Thursday, Fujimori announced a team of lawyers appointed by her party to challenge the validity of the 250,000 votes cast at 900 voting tables in almost poor rural areas.
We have the right to know the truth, said Fujimori.
Attorneys at her party have stated that they will provide evidence of fraud to agencies such as the Organization of American States and the European Union. International observers have previously stated that they consider elections clean and transparent.
(Report by Marco Aquino and Stefanie Eschenbacher, Written by Aislinn Laing, Edited by Rosalba OBrien)
Perus Election Commission says it is working at maximum speed to resolve election questions
Source link Perus Election Commission says it is working at maximum speed to resolve election questions
Read the original here:
Posted in Abolition Of Work
Comments Off on Peru’s Election Commission says it is working at maximum speed to resolve election questions – Texasnewstoday.com
World Cell and Gene Therapy Manufacturing Market Report 2021: The Rise of CMOs & CDMOs – Funding the Cell and Gene Therapy Boom -…
Posted: at 7:37 am
DUBLIN--(BUSINESS WIRE)--The "The Market for Cell and Gene Therapy Manufacturing - The Rise of CMOs & CDMOs (2021)" report has been added to ResearchAndMarkets.com's offering.
Funding the Cell and Gene Therapy Boom
The rapid ascension of cell and gene therapies (CGT) has created a crucial turning point in the history of modern medicine. Not only have new therapies such as CAR-T produced a shift towards highly individualized medicine and a powerful new front in the war against cancer, but the rapidity of change with the CGT sector has taken the world by storm.
By 2025, the FDA has indicated that it will be reviewing an estimated 10 to 20 of CGTs per year, while the European Medicines Agency (EMA), has estimated that it will soon be approving as many as a dozen such therapies per year.
With the hard-earned marketing approvals gained by cell and gene therapy companies in recent years, biopharmaceutical companies have substantially increased their interest in the CGT sector. Some biopharma companies are resorting to increasing their manufacturing capacity by investing in expansion and new facilities, while others are partnering with third-party contract manufacturing organizations to outsource this work.
With the future in mind, contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) are also investing heavily in expanding their manufacturing capacity to be able to take on new clients and larger, later-stage projects as the market expands.
Currently, the cell and gene therapy field is currently on track for a massive capacity shortage. In particular, there is likely to be a shortage of manufacturing capacity at the commercial scale. Although approximately 90% of cell and gene therapy developers would prefer to use CMOs, related CMO capacity is not available within the industry.
Moreover, the lead time for CMOs to begin cell and gene therapy projects averages over 18 months. Thus, CGT developers are often forced to expand their in-house capacity. Of course, CMOs are also investing heavily into the expansion of their cell and gene therapy manufacturing capabilities, but these large build-outs take time.
This report is tailed to the strategic needs of cell and gene therapy (CGT) companies, as well as the CMOs and CDMOs who are handling third-party manufacturing services for these clients. With the competitive nature of this global market, you don't have the time to do the research. Claim this report to become immediately informed, without sacrificing hours of unnecessary research or missing critical opportunities.
In compiling this report, the research analysts leveraged nearly a decade of historical data on the cell and gene therapy manufacturing industry. In addition to conducting extensive secondary research, our analysts interviewed dozens of highly regarded industry leaders.
Key Topics Covered:
1. Funding the Cell and Gene Therapy Boom
1.1 Recent CMO/CDMO Expansions in Cell and Gene Therapy Sector
1.1.1 Expected Capacity Crunch
1.1.2 Investments for CGT Capacity Expansion
1.1.3 Other CGT Manufacturing Investments
1.1.4 Events Driving Expansion for CGT Facilities and Infrastructure
2. Recent Merger and Acquisition (M&A) Deals within the Cell and Gene Therapy Sector
2.1 Charles River Laboratories International/Retrogenix
2.2 Charles River Laboratories International/Cognate BioServices
2.3 Beam Therapeutics/Guide Therapeutics
2.4 Thermo Fisher Scientific/Henogen
2.5 Eli Lilly/Prevail Therapeutics
2.6 Novartis/Vedere Bio
2.7 Bayer/Asklepios
2.8 AGC Biologics/MolMed
2.9 Sorrento Therapeutics/SmartPharm
2.10 Catalent/MaSTherCell
2.11 ElevateBio
2.12 Ixaka
3. Financing Rounds
3.1 Major Private Placements
3.1.1 Orchard Therapeutics
3.1.2 Amryt
3.1.3 BioNTech
3.1.4 Kiadis Pharma
3.2 Major Venture Capital Financings
3.2.1 ElevateBio
3.2.2 Century Therapeutics
3.2.3 Artiva Biotherapeutics, Inc.
3.2.4 Vineti, Inc.
3.2.5 Ori Biotech Ltd.
3.2.6 Neogene Therapeutics
3.2.7 Forge Biologics
3.2.8 Sana Biotechnology
3.2.9 Orca Bio
3.2.10 Freeline Therapeutics
3.2.11 Poseida Therapeutics
3.2.12 Kriya Therapeutics
3.2.13 Legend Biotech Corporation
3.2.14 Lyell Immunopharma
3.2.15 Mammoth Biosciences
3.2.16 Kyverna Therapeutics
3.3 Major Corporate Partnerships within the CGT Market
3.3.1 Bayer/Atara Biotherapeutics
3.3.2 Novartis/Mesoblast
3.3.3 Novartis/Sangamo
3.3.4 Janssen Biotech/Fate Therapeutics
3.3.5 Biogen/Sangamo
3.4 Follow-on Public Offerings by CGT Companies
3.4.1 Rocket Pharmaceuticals
3.4.2 Adaptimmune Therapeutics
3.4.3 Allogene Therapeutics
3.4.4 Iovance Biotherapeutics, Inc.
3.4.5 Bluebird bio
3.5 Initial Public Offerings (IPO)
3.5.1 Legend Biotech
3.5.2 Decibel Therapeutics
3.5.3 Sana Biotechnology
3.5.4 Rocket Pharmaceuticals
3.5.5 JW Therapeutics
3.5.6 AlloVir
3.5.7 Akouos
3.5.8 Generation Bio
3.5.9 Passage Bio
3.5.10 Beam Therapeutics
4. Market Size for Cell and Gene Therapy CMO/CDMOs
5. Profiles of Cell and Gene Therapy CMOs and CDMOs
5.1 3P Biopharmaceuticals
5.2 ABL, Inc.
5.3 AGC Biologics
5.4 Advent BioServices Ltd.
5.5 Akron Biotech
5.6 Aldevron
5.7 Anemocyte S.r.l
5.8 Applied Viromics
5.9 ATVIO Biotech, Ltd./Orgenesis Biotech Israel, Ltd.
5.10 Austrianova
5.11 Avid Bioservices, Inc.
5.12 Batavia Biosciences B.V.
5.13 Bio Elpida
5.14 BioCentriq
5.15 BioNTech IMFS GmbH
5.16 BioReliance Corporation/Merck Millipore
5.17 Bio-Techne
5.18 Biovian Oy
5.19 Boehringer Ingelheim BioXcellence
5.20 Brammer Bio/Thermo Fisher Scientific
5.21 C3i
5.22 Catalent Biologics
See more here:
World Cell and Gene Therapy Manufacturing Market Report 2021: The Rise of CMOs & CDMOs - Funding the Cell and Gene Therapy Boom -...
Posted in Gene Medicine
Comments Off on World Cell and Gene Therapy Manufacturing Market Report 2021: The Rise of CMOs & CDMOs – Funding the Cell and Gene Therapy Boom -…
Cost watchdog ICER will bless some high-priced gene and cell therapies, but only with solid proof of benefit: Analyst – FiercePharma
Posted: at 7:37 am
On the surface, it may seem that the higher the price of a new medicine, the harder it is for its developer to get a thumbs-up from drug-price watchdog Institute for Clinical and Economic Review (ICER). For companies in the rapidly growing gene and cell therapy field, that would make ICERs review a tough hurdle to overcome, particularly if the agencys opinions take on more weight in determining insurance coverage decisions in the future.
But analysts at Mizuho Securities dug into most of ICERs verdicts on gene and cell therapies to date and found a surprising trend: The institutes reviewers have deemed more than half the products they reviewed so far to be cost-effective. And the evidence they used to reach those positive conclusions offers important lessons on research, development and pricing to developers of the next generation of gene and cell therapies, said analyst Difei Yang, Ph.D., the lead author of two reports Mizuho sent to clients last week, in an interview.
Clearly, theyre looking at the amount of time the patient gainsbut also the quality of life, Yang said. Companies that put in the effort to provide robust data proving a gene or cell therapy could outperform the standard of care on both measureshead-to-head trials, solid evidence of long-term benefit and so forthhad a higher likelihood of a positive ICER verdict on cost-effectiveness, Mizuho found.
Makers of CAR-T cancer cell therapies have so far been much more successful at proving superiority over the standard of care than have manufacturers of gene therapies for rare diseases, Mizuho noted. ICER approved of the cost-effectiveness of the first two CAR-Ts on the market, Gileads Yescarta for lymphoma and Novartis Kymriah for lymphoma and leukemia, both approved in 2017 and launched at $373,000 and $475,000, respectively. And the agency has already said it will give the thumbs-up to the yet-to-be-approved multiple myeloma CAR-T cilta-cel from Janssen and Legend Biotechprovided that it is priced at $475,000 or less.
Only one of four CAR-Ts that ICER reviewed did not hit the cost-effectiveness threshold: Bristol Myers Squibbs ide-cel for multiple myeloma, which was launched this spring with the brand name Abecma at a price of $419,500. A spokesperson for BMS griped at the time that ICER relied on inappropriate modeling of ide-cels overall survival data and a misguided view of retreatment.
ICERs president Steve Pearson, M.D.,cited important evidence gaps in the data available to the agency while it was reviewing the cost-effectiveness of multiple myeloma treatments.
Pearson said in an interview that ICERs reviewers sometimes struggle to determine how data from what are often brief studies will translate to real-world outcomes. We need to see longer-term data that we can connect to what were seeing in the short term, Pearson said. What we really want to see are patient-relevant outcomes, like how well theyre functioning and their quality of life.
Often, companies fall short when it comes to providing data that provide a clear contrast between patients who receive gene or cell therapies and those who do not, Pearson said. They may say [non-treated] patients would only have six months to live, but sometimes the comparison is just not that clean, he said. [Or] the [standard-of-care] data may be 10 years old. We know that care changes over 10 years.
BMS took a step in that direction with another CAR-T in its portfolio, Breyanzi, which was approved in February for large B-cell lymphoma. Last week, it released trial data showing an improvement in event-free survival in patients who received the CAR-T treatment versus those who were treated with the gold standard, Roches Rituxan, high-dose chemotherapy and stem cell transplant.
It is too early to define Breyanzis ability to extend lives, but BMS hopes the data will ultimately move the CAR-T earlier in the treatment regimen and set the product apart from lymphoma rivals Yescarta and Kymriah. Breyanzi was introduced at a list price of $410,300. ICER has not yet reviewed the product.
Mizuhos Yang says being able to getthe green light for earlier treatment may be the motivation for such head-to-head trials, and, ultimately, these data would likely bring ICER on board with high-priced cell and gene therapies, too. The earlier you treat the patient, the better off they are. And the better off they are, the lower the net cost will be to the healthcare system, she says.
RELATED: Bristol's new myeloma CAR-T needs a hefty discount to be cost-effective, watchdogs say while endorsing GSK's Blenrep
Gene therapies, on the other hand, have received mixed reviews from ICER on cost-effectiveness. Take Spark Therapeutics Luxturna, which is approved for a rareinherited disease that causes blindness for those aged one year and older. ICER found that the product, whichlaunched at $850,000, would be cost-effective if given to patients at the age of threebut not if patients were dosed at age 15 or later, because by that time they would have already lost a significant amount of eyesight.
Yang attributed the verdict to the cost of care. ICER tries to quantify how much a caregiver costs, so if the child is treated earlier, the idea would be that theyre more independent, they require less care, Yang says. If theyre treated at 15, a lot of that cost has already happened. And this message is consistent with gene therapy in general.
But Pearson said ICERs reviewers placed more weight on the overall value to society of preventing blindness. There really are no significant healthcare costs for being blind, he said. But society saves money to a certain extent, because educational costs are lower, patients have full careers and higher earnings potential if theyre fully sighted.
ICER initially balked at Novartis' $2.1 million gene therapy for spinal muscular atrophy (SMA), Zolgensma, but it didn't approve of Biogen's SMA drug Spinraza either. Spinraza launched at up to $750,000 for the first year and half that every year thereafter, prompting ICER to ultimatelydetermine Zolgensma is the lesser of two evils on cost.
BioMarins Roctavian, a hemophilia gene therapy, has hit some bumps on the road to approval, but ICER has already determined how it would be cost-effective. Using a placeholder price of $2.5 million, ICER estimated if the gene therapy is durable for a dozen years, it would save the healthcare system about $5 million per patient compared to chronically dosed factor VIII. Thats an example of where gene therapy can really bring down [costs], Yang said.
RELATED: ICER's blasted pharma pricing for years, but now drugmakers are 'rolling up their sleeves' to cooperate
After delving into ICERs methodology, Yang said she came away with one bone to pick with the agency. Right now, their judgments are based on clinical valuation, but there should be some sort of consideration for the value of innovation, she said. We learn something along the way, and there has to be long-lasting value in that. I dont think thats being captured.
Pearsons response? We are sensitive to the idea that theres value in having treatments that take different approaches, but we dont consider innovation as something thats separate from the benefits to patients and families, he said. Innovation matters to patients to the degree it helps them live better lives. If its not better for patients, Im not sure we should be paying more for it.
ICER has recently boosted its efforts to maintain an ongoing dialogue with biopharma developers and insurance companies. The agency adopted a formal 12-month checkup policy for each of its published reports, Pearson said. If any new data have been released during that time, reviewers may revisit their original verdict.
It also introduced ICER Analytics, a cloud-based portal that houses all of its economic models. Life sciences companies and insurers can subscribe to ICER Analytics. If [a drugmaker] has new evidence, or if they disagreed with our assumptions the first time around, they can put in their own information and create a different result on fair price, Pearson said. Well put that side by side with our original results so payers can see it. More than 50 companies have signed up for trial subscriptions since ICER Analytics launched in November, he said.
Read the original:
Cost watchdog ICER will bless some high-priced gene and cell therapies, but only with solid proof of benefit: Analyst - FiercePharma
Posted in Gene Medicine
Comments Off on Cost watchdog ICER will bless some high-priced gene and cell therapies, but only with solid proof of benefit: Analyst – FiercePharma
CRISPR Therapeutics and Capsida Biotherapeutics Announce – GlobeNewswire
Posted: at 7:37 am
- Collaboration leverages expertise and capabilities of both companies towards developing life-changing treatments for severe neurological diseases -
ZUG, Switzerland and CAMBRIDGE, Mass. and THOUSAND OAKS, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, and Capsida Biotherapeutics Inc., a biotechnology company dedicated to developing breakthrough gene therapies using fully integrated adeno-associated virus (AAV) engineering, cargo development and manufacturing, today announced a strategic partnership to research, develop, manufacture and commercialize in vivo gene editing therapies delivered with engineered AAV vectors for the treatment of familial amyotrophic lateral sclerosis (ALS) and Friedreichs ataxia.
Under the agreement, CRISPR Therapeutics will lead research and development of the Friedreichs ataxia program and perform gene-editing activities for both programs, and Capsida will lead research and development of the ALS program and conduct capsid engineering for both programs. Capsidas high-throughput AAV engineering platform generates capsids optimized to target specific tissue types and limits transduction of tissues and cell types that are not relevant to the target disease, potentially allowing for improved efficacy and safety. CRISPR Therapeutics and Capsida will each have the option to co-develop and co-commercialize the program that the other company leads. Following such option, the companies would equally share all research, development and commercialization costs and profits worldwide related to the collaboration product. As part of the collaboration, Capsida will also be responsible for process development and clinical manufacture of both programs and have the option to manufacture commercial products generated under the agreement.
We are excited to enter this collaboration with Capsida. The combination of Capsidas AAV engineering platform and CRISPR Therapeutics gene-editing platform has the potential to enable transformative gene-edited therapies for patients with neurological diseases, said Samarth Kulkarni, Ph.D., Chief Executive Officer of CRISPR Therapeutics. This new partnership is one more step in our overall strategy of bringing together innovative and complementary technologies to unlock the full potential of our core platform.
Bringing together Capsidas fully integrated, tissue targeting gene therapy platform with CRISPR Therapeutics leading gene-editing capabilities gives us the potential to develop first-in-class gene therapies for patients with severe neurological disorders and expand the reach of Capsidas broadly enabling capabilities, said Robert Cuddihy, M.D., Chief Executive Officer of Capsida Biotherapeutics.
AboutCRISPR Therapeutics
CRISPR Therapeuticsis a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA.CRISPR Therapeuticshas established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts,CRISPR Therapeuticshas established strategic collaborations with leading companies includingBayer, Vertex Pharmaceuticals andViaCyte, Inc.CRISPR Therapeutics AGis headquartered inZug, Switzerland, with its wholly-ownedU.S.subsidiary,CRISPR Therapeutics, Inc., and R&D operations based inCambridge, Massachusetts, and business offices inSan Francisco, CaliforniaandLondon, United Kingdom. For more information, please visitwww.crisprtx.com.
CRISPR THERAPEUTICS word mark and design logo are registered trademarks ofCRISPR Therapeutics AG. All other trademarks and registered trademarks are the property of their respective owners.
CRISPR Therapeutics Forward-Looking StatementThis press release may contain a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements made by Dr. Kulkarni and Dr. Cuddihy in this press release, as well as statements regarding CRISPR Therapeutics expectations about any or all of the following: (i) the future activities of the parties pursuant to the collaboration and the expected benefits of CRISPR Therapeutics collaboration with Capsida; and (ii) the therapeutic value, development, and commercial potential of CRISPR/Cas9 gene editing technologies and therapies. Without limiting the foregoing, the words believes, anticipates, plans, expects and similar expressions are intended to identify forward-looking statements. You are cautioned that forward-looking statements are inherently uncertain. Although CRISPR Therapeutics believes that such statements are based on reasonable assumptions within the bounds of its knowledge of its business and operations, forward-looking statements are neither promises nor guarantees and they are necessarily subject to a high degree of uncertainty and risk. Actual performance and results may differ materially from those projected or suggested in the forward-looking statements due to various risks and uncertainties. These risks and uncertainties include, among others: CRISPR Therapeutics may not realize the potential benefits of the collaboration; uncertainties inherent in the initiation and completion of preclinical studies, including availability and timing of results from preclinical studies; whether results from a preclinical study will be favorable and predictive of future results of future studies or clinical trials; uncertainties about regulatory approvals and that future competitive or other market factors may adversely affect the commercial potential for product candidates; potential impacts due to the coronavirus pandemic, such as the timing and progress of preclinical studies; uncertainties regarding the intellectual property protection for CRISPR Therapeutics technology and intellectual property belonging to third parties, and the outcome of proceedings (such as an interference, an opposition or a similar proceeding) involving all or any portion of such intellectual property; and those risks and uncertainties described under the heading "Risk Factors" in CRISPR Therapeutics most recent annual report on Form 10-K, quarterly report on Form 10-Q, and in any other subsequent filings made by CRISPR Therapeutics with the U.S. Securities and Exchange Commission, which are available on the SEC's website at http://www.sec.gov. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. CRISPR Therapeutics disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent required by law.
About Capsida Biotherapeutics
Capsida Biotherapeutics Inc. is developing tissue-targeted gene therapies using its biologically driven, high-throughput adeno-associated virus (AAV) engineering and proprietary cargo development platform. As a fully integrated gene therapy company, Capsida is combining its differentiated AAV engineering and screening capabilities with cargo development and state-of-the-art manufacturing to establish a proprietary pipeline of groundbreaking gene therapies across a range of therapeutic areas for indications that are unreachable with current technologies. The companys leadership is backed by decades of successful biologics manufacturing experience and deep AAV biology expertise. Visit us at http://www.capsida.com to learn more.
CRISPR Therapeutics Investor Contact:Susan Kim+1-617-307-7503susan.kim@crisprtx.com
CRISPR Therapeutics Media Contact:Rachel Eides+1-617-315-4493rachel.eides@crisprtx.com
Capsida Media Contact:Greig Communications, Inc.Kathy Vincent+1-310-403-8951kathy@greigcommunications.com
More:
CRISPR Therapeutics and Capsida Biotherapeutics Announce - GlobeNewswire
Posted in Gene Medicine
Comments Off on CRISPR Therapeutics and Capsida Biotherapeutics Announce – GlobeNewswire